PharmaCyte Biotech Inc (PMCB)

[bulldurham]

ATTENTION: Nuvilex, Inc. Releases Industry-Changing News Today!!

Dr. Von Hoff is a member of the Pancreatic Cancer "Dream Team" and is world renowned for his contributions to pancreatic cancer research in addition to the development of new cancer drugs.

Having Dr. Von Hoff play a leading role in Nuvilex's clinical trials for advanced, inoperable pancreatic cancer... will almost guarantee FDA approval of it's Cell-in-a-Box® treatment for the disease.

Dr. Von Hoff started the development of Gemzar® (gemcitabine) for Eli Lilly... which became the "Gold Standard" single agent treatment for advanced pancreatic cancer and has made Eli Lilly many billions of dollars in profits.

Dr. Von Hoff then led Celgene and its drug Abraxane® to FDA approval as the new "Gold Standard" treatment for advanced pancreatic cancer when he not only lead those clinical trials, but got Abraxane® "Fast Tracked" through the approval process with the FDA.

bull